The Corporate/Industry Sponsored Clinical Trial Policy Statement has been updated.  The policy remains consistent with previous versions, except for a change to the F&A rate.  The current required F&A rate of 25% of total direct costs will increase to 26% of total direct costs effective July 1, 2016.  The revised policy can be found here: http://gao.fo.uiowa.edu/corporate-and-industry-sponsored-projects-policy-statement-0

If you have any questions, please contact Audra Haddy (audra-haddy@uiowa.edu).